These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8116730)
1. Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Hofmann GE; Glatstein I; Schatz F; Heller D; Deligdisch L Am J Obstet Gynecol; 1994 Feb; 170(2):671-6. PubMed ID: 8116730 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators and inhibitors are transcribed during early macaque implantation. Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823 [TBL] [Abstract][Full Text] [Related]
3. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Floridon C; Nielsen O; Holund B; Sunde L; Westergaard JG; Thomsen SG; Teisner B Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826 [TBL] [Abstract][Full Text] [Related]
4. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Floridon C; Nielsen O; Hølund B; Sweep F; Sunde L; Thomsen SG; Teisner B Placenta; 2000 Nov; 21(8):754-62. PubMed ID: 11095924 [TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241 [TBL] [Abstract][Full Text] [Related]
6. Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer. Naitoh H; Eguchi Y; Ueyama H; Kodama M; Hattori T Jpn J Cancer Res; 1995 Jan; 86(1):48-56. PubMed ID: 7737909 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 may participate in regulating trophoblast invasion in human placentae throughout gestation. Pang ZJ; Zhou JG; Huang LP Am J Reprod Immunol; 2008 Jul; 60(1):19-25. PubMed ID: 18593434 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas. Gris JC; Schved JF; Marty-Double C; Mauboussin JM; Balmes P Chest; 1993 Jul; 104(1):8-13. PubMed ID: 7686838 [TBL] [Abstract][Full Text] [Related]
9. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta. Nishida Y; Hayashi Y; Imai Y; Itoh H Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056 [TBL] [Abstract][Full Text] [Related]
10. Endometrial and embryonic factors involved in successful implantation. Bulletti C; Polli V; Licastro F; Parmeggiani R Ann N Y Acad Sci; 1994 Sep; 734():221-31. PubMed ID: 7978920 [No Abstract] [Full Text] [Related]
11. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950 [TBL] [Abstract][Full Text] [Related]
12. The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study. Häckel C; Radig K; Röse I; Roessner A Anat Embryol (Berl); 1995 Oct; 192(4):363-8. PubMed ID: 8554169 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients. Borstnar S; Vrhovec I; Svetic B; Cufer T Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538 [TBL] [Abstract][Full Text] [Related]
14. Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study. Takeuchi Y; Nakao A; Harada A; Nonami T; Fukatsu T; Takagi H Am J Gastroenterol; 1993 Nov; 88(11):1928-33. PubMed ID: 8237943 [TBL] [Abstract][Full Text] [Related]
15. High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities. Yagel S; Geva TE; Solomon H; Shimonovitz S; Reich R; Finci-Yeheskel Z; Mayer M; Milwidsky A J Clin Endocrinol Metab; 1993 Dec; 77(6):1506-11. PubMed ID: 8263134 [TBL] [Abstract][Full Text] [Related]
16. [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system]. Bouchet C; Hacène K; Martin PM; Becette V; Tubiana-Hulin M; Lasry S; Oglobine J; Spyratos F Pathol Biol (Paris); 2000 Nov; 48(9):825-31. PubMed ID: 11141918 [TBL] [Abstract][Full Text] [Related]
17. Fibronectinase activity in cultured human trophoblasts is mediated by urokinase-type plasminogen activator. Monzón-Bordonaba F; Wang CL; Feinberg RF Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):58-65. PubMed ID: 9024090 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of transforming growth factor-beta in human implantation sites. Selick CE; Horowitz GM; Gratch M; Scott RT; Navot D; Hofmann GE J Clin Endocrinol Metab; 1994 Mar; 78(3):592-6. PubMed ID: 7510303 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Feinberg RF; Kao LC; Haimowitz JE; Queenan JT; Wun TC; Strauss JF; Kliman HJ Lab Invest; 1989 Jul; 61(1):20-6. PubMed ID: 2473276 [TBL] [Abstract][Full Text] [Related]
20. Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Graham CH; Lysiak JJ; McCrae KR; Lala PK Biol Reprod; 1992 Apr; 46(4):561-72. PubMed ID: 1374270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]